HIGHLIGHTS
- who: Report and colleagues from the Medicine, University of Kentucky, Lexington, USA Department of Cardiology, Fairview Hospital, Cleveland Clinic have published the research: Review began 05/10/2022 Review ended 05/17/2022 Published 05/21/2022 u00a9 Copyright, in the Journal: (JOURNAL) of May/21,/2022
- what: COVID-19-induced hypercoagulability can lead to a myriad of thrombo-embolic complications.
- future: Research is needed to determine the role of percutaneous coronary interventions anticoagulation and antiplatelet agents in these patients.
SUMMARY
As of March 2022, about 487 million individuals . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.